In the past 12 months, Willie Nelson launched a product line of CBD-infused coffee beans called ‘Willie’s Remedy’, Kim Kardashian came out and told the world she hoped her upcoming baby shower was ‘CBD-themed’, and Mandy Moore told everyone listening at the Golden Globes that she was using CBD oil to soothe her aching feet after wearing high heels. The world has gone nuts on CBD, it seems.

In other words, 2020 is looking to be a good year for the CBD industry.

Perhaps it will even be the year that the general public stops looking at the seemingly magical, hemp-derived product so dubiously and begins embracing it in the mainstream. For several years now CBD products like Organic CBD Nugs, oils, capsules and topical creams have been floating on the periphery of society, sneaking their way into beverages, facial creams - even dog treats - but not quite receiving the official, blanket tick of approval from regulatory authorities worldwide. To varying degrees, governments worldwide have legalised CBD - or forms of it - but it wasn’t until the United States FDA approved CBD (Epidiolex) as an effective medicine for treating epilepsy that the world has truly sat up and began noticing the enormous potential that the naturally occurring component of cannabis can offer.

The CBD market’s sub-markets are also set to expand: the global nanoemulsion market - which is predicted to be one of the largest sub-markets in the cannabis industry - is estimated to rise to $14.91 billion by the end of 2025 and other current industry reports are showing that the recreational cannabis beverage industry is also on the rise.

Recent industry analysis shows that over the next five years Europe’s CBD market is set to grow by 400%, while the global CBD market is expected to grow at a rapid rate too, reaching $23.6 billion by 2026, according to Grand View Research. In fact, some predict it will happen even sooner: leading cannabis research firms BDS Analytics and Arcview Market Research estimate that the US market for CBD sales will surpass $20 billion by 2024.

The CBD industry has reached new heights in 2020

Looking good should make new highs

Sales will keep on growing worldwide

A German CBD oil manufacturer has launched three products at one of Germany’s main drugstore chains.

CannaCare Health GmbH said its CANOBO products hit the shelves at 2,200 branches of ROSSMANN drugstore across Germany in February 2020.

Prohibition Partners has predicted that the global CBD health and beauty industry could be worth up to $959 million by 2024. That’s up from an estimated $710 million in 2018. Many large health and beauty companies, including L’oreal and Estee Lauder, have already made moves to enter the CBD industry through the acquisition of smaller CBD companies.

The most quoted of CBD’s benefits are its potential as an anti-inflammatory and anti-oxidant. It is also believed to be effective at reducing stress and anxiety and promoting sleep.

I don't think we will see lower

Long and strong, bounce coming...

Let's see this week

Bottom is in

Home Healthcare Expansion. As detailed in recent releases, the Company has begun the process of expanding its home healthcare operations outside of the state of Texas, moving into in Nevada (Las Vegas and Reno), New Mexico (Santa Fe), Arizona (Phoenix), and Florida (The Villages). As part of that process, the Company has established a registered agent in New Mexico. Regulatory requirements for each of these locations are in progress.

Upcoming Annual Financials. The Company will be releasing its financial data for 2019 on or before March 31, 2020. That audited report will include, among other data, a $70k q/q increase in revenues from its home healthcare segment, representing another large sequential quarterly jump in performance (of roughly 39%), which amounts to accelerating top-line growth.

Name Change and Uplist. To better serve the interests of its shareholders, the Company has decided to change its corporate name to ISW Holdings, Inc. Steps toward this objective have already begun. In addition, as previously announced in a press release dated Oct. 29, 2019, the Company plans to uplist shares onto the OTCQB exchange following the release of fully audited financial data for the four quarters ended December 31, 2019.

The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace with VOLUM.

ISWH is creating and managing brands across a spectrum of disruptive industries. The Company has now established itself as a health and wellness leader with a focus on reshaping the wellness and restoration products and home healthcare markets through state-of-the-art technology and execution.

ISWH nurtures emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution.

Yup

Moves on low volume

Should be low imo

ISWH is a brand management holdings company with diverse operational interests in the adult beverage industry, wellness and restorations, home healthcare markets, and development-stage operations in the logistics and supply chain and renewable energy markets. 

The Company also wishes to inform shareholders that it will be making a significant partnership announcement in coming days.

Pierce continued, “We were in the right place at the right time to provide support and help communities survive this tragic process. We expect continued sharp growth in revenues and clients served in Q1 and Q2, driven by the coronavirus outbreak. We will provide frequent progress updates for our shareholders as we ramp up operations in new regional service areas. We also plan to continue to expand given our strong margins and our expectation that we are unfortunately still in the early innings of this crisis.”

The Company believes this expansion move has implications that stretch far beyond the immediate COVID-19 crisis. According to a recent report from Business Insider Intelligence, the US home healthcare market is projected to grow from $103 billion in 2018 to $173 billion by 2026 — outpacing growth in all other care types, including hospital care (+5.3% annually) and physician services (+5.6% annually).

The Company is already taking on additional clients in the Houston, San Antonio, and El Paso service areas. As noted in prior communications, the Company has also begun the process of expanding its home healthcare operations outside of the state of Texas, moving into in Nevada (Las Vegas and Reno), New Mexico (Santa Fe), Arizona (Phoenix), and Florida (The Villages). As part of that process, the Company has established a registered agent in New Mexico. Regulatory requirements for each of these locations are in progress.

Management notes that, in addition to providing care for chronically disabled or ill home care clients, the Company has positioned itself to act as a supportive mechanism in the event of overflow conditions in the conventional healthcare system. The COVID-19 pandemic represents just such a catalyst, and the Company stands ready to handle a surge in clients as hospitals are forced to discharge patients to home care in order to make room for additional intensive care resources for those suffering from this disease.

We are waiting for final regulatory approval, and then we will aggressively launch services in Nevada, New Mexico, Arizona, and Florida, to accompany our current growing operations in Texas.

We are receiving a flood of calls every day as hospitals prepare for overwhelming circumstances,” commented Alonzo Pierce, President of ISWH.

ISW Holdings, Inc. (OTCMKTS: ISWH) (“ISW”, “ISWH”, or the “Company”), an emerging diversified leader in the healthcare and data infrastructure markets, is excited to provide current and prospective investors with a progress update as the Company expands its Home Healthcare operations in response to the tangible opportunity created by the tragic COVID-19 outbreak, and its dramatic impact on the conventional US healthcare system.

ISWH Home Healthcare Progresses Toward Major Expansion as Demand Soars on COVID-19 Threa

We good here just need more volume on the ask side

$ISWH Home Healthcare Progresses Toward Major Expansion as Demand Soars on COVID-19 Threat https://t.co/hZZejpOIdT $IBB $GILD $NVS $JNJ $CELG $BSX $PFE #coronavirus #Covid_19

$ISWH Home Healthcare Progresses Toward Major Expansion as Demand Soars on COVID-19 Threat https://t.co/hZZejpOIdT $IBB $GILD $NVS $JNJ $CELG $BSX $PFE #coronavirus #Covid_19

What's up guys

$ISWH Home Healthcare Progresses Toward Major Expansion as Demand Soars on COVID-19 Threat http://www.globenewswire.com/news-release/2020/03/25/2006191/0/en/ISWH-Home-Healthcare-Progresses-Toward-Major-Expansion-as-Demand-Soars-on-COVID-19-Threat.html $IBB $GILD $NVS $JNJ $CELG $BSX $PFE

$ISWH Home Healthcare Progresses Toward Major Expansion as Demand Soars on COVID-19 Threat http://www.globenewswire.com/news-release/2020/03/25/2006191/0/en/ISWH-Home-Healthcare-Progresses-Toward-Major-Expansion-as-Demand-Soars-on-COVID-19-Threat.html $IBB $GILD $NVS $JNJ $CELG $BSX $PFE

$ISWH Announces Further Steps to Expand Home Healthcare Operations in Preparation for a Coronavirus Outbreak in the US https://otcmarkets.com/stock/ISWH/news/ISWH-Announces-Further-Steps-to-Expand-Home-Healthcare-Operations-in-Preparation-for-a-Coronavirus-Outbreak-in-the-US?id=255749… $INDU $SPY $SPX $AAPL $IBB $GILD $NVS $BMY $CELG $PFE $JNJ #coronavirus